Zobrazeno 1 - 5
of 5
pro vyhledávání: '"R D, Carvajal"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-5 (2019)
Abstract Background Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events. Case presentation We rep
Externí odkaz:
https://doaj.org/article/b989977539fe4b47916491fc5bca37e4
Autor:
S. Piperno-Neumann, M. S. Carlino, V. Boni, D. Loirat, F. M. Speetjens, J. J. Park, E. Calvo, R. D. Carvajal, M. Nyakas, J. Gonzalez-Maffe, X. Zhu, M. D. Shirley, T. Ramkumar, A. Fessehatsion, H. E. Burks, P. Yerramilli-Rao, E. Kapiteijn
Publikováno v:
British Journal of Cancer, 128, 1040-1051. SPRINGERNATURE
Background Up to 50% of patients with uveal melanoma develop metastases (MUM) with a poor prognosis and median overall survival of approximately 1 year. Methods This phase I study evaluated the safety, tolerability, pharmacokinetics, pharmacodynamics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc13a7b6997fe71f8832691ca2f3966f
http://hdl.handle.net/1887/3566795
http://hdl.handle.net/1887/3566795
Autor:
F, Dimitriou, K, Namikawa, I L M, Reijers, E I, Buchbinder, J A, Soon, A, Zaremba, P, Teterycz, M J, Mooradian, E, Armstrong, Y, Nakamura, M G, Vitale, L E, Tran, X, Bai, C, Allayous, S, Provent-Roy, A, Indini, P, Bhave, M, Farid, K C, Kähler, I, Mehmi, V, Atkinson, O, Klein, C J, Stonesifer, F, Zaman, A, Haydon, R D, Carvajal, O, Hamid, R, Dummer, A, Hauschild, M S, Carlino, M, Mandala, C, Robert, C, Lebbe, J, Guo, D B, Johnson, P A, Ascierto, A N, Shoushtari, R J, Sullivan, B, Cybulska-Stopa, P, Rutkowski, L, Zimmer, S, Sandhu, C U, Blank, S N, Lo, A M, Menzies, G V, Long
Mucosal melanoma (MM) is a rare melanoma subtype with distinct biology and poor prognosis. Data on the efficacy of immune checkpoint inhibitors (ICIs) are limited. We determined the efficacy of ICIs in MM, analyzed by primary site and ethnicity/race.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc56111b83de57d0e398a5cc2f06c3a3
https://www.ncbi.nlm.nih.gov/pubmed/35716907
https://www.ncbi.nlm.nih.gov/pubmed/35716907
Publikováno v:
Sarcoma, Vol 2015 (2015)
Externí odkaz:
https://doaj.org/article/749392d6d05044cfac256e6c00cd77d7
Publikováno v:
Sarcoma, Vol 2014 (2014)
Sarcomas are heterogeneous malignant tumors of mesenchymal origin characterized by more than 100 distinct subtypes. Unfortunately, 25–50% of patients treated with initial curative intent will develop metastatic disease. In the metastatic setting, c
Externí odkaz:
https://doaj.org/article/f4d00a735ecc46b48a05f16cddde7b90